ADVERTISEMENT
The president said “in 2024, a study from Stanford University, 30 special operation veterans with traumatic brain injuries underwent — it’s called ibogaine treatment — ibogaine, remember the name,” noting that they “experienced an 80 to 90% reduction in symptoms of depression and anxiety within one month.”
President Trump announces a new Executive Order that directs the FDA to expedite reviews of psychedelics that have been designated as breakthrough therapy drugs:
“If these turn out to be as good as people are saying, it’s going to have a tremendous impact on this… pic.twitter.com/Kut2RHohbQ
ADVERTISEMENT
